1Olsen E, Thyregaard R, Kill J. Esophacoil expanding stent in the management of patients with nonresectable malignant esophageal or cardiac neoplasm: a prospective study. Endoscopy, 1999,31: 417～420.
2Lambert R. Treatment of esophagogastric tumors.Endoscopy, 2000, 32: 322～330.
3Birch JF, White SA, Berry DP, Veitch PS. A costbenefit comparison of self-expanding metal stents and Atkinson tubes for the palliation of obstructing esophageal tumors. Dis Esophagus, 1998, 11:172～176.
4Chan AC, Shin FG, Lam YH, Sung JJ, Lau JY,Chung SC. A comparison study on physical properties of self-expandable esophageal metal stents.Gastrointest Endosc, 1999, 49: 462～465.
5Bartelsman JF, Bruno MJ, Jensema AJ, Haringsma J, Reeders JW, Tytgat GN. Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprosthesis: experiences in 153 patients. Gastrointest Endosc, 2000, 51: 134～138.
6Mayoral W, Fleischer D, Salcedo J, Roy P, A1Kawas F, Benjamin S. Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest Endosc, 2000, 51: 556～559.
8Oikarinen H, Leinonen S, Karttunen A, Tikkakoski T, Hetemaa T, Makela J, Paivansalo M. Patency and complications of percutaneously inserted metallic stents in malignant biliary obstruction. J Vasc Interv Radiol, 1999, 10: 1387～1393.
9Liu Q, Khay G, Cotton PB. Feasibility of stent placement above the sphincter of Oddi ("insidestent") for patients with malignant biliary obstruction. Endoscopy, 1998, 30: 687～690.
10Pedersen FM, Lassen AT, Schaffalitzky de Muckadell OB. Randomized trial of stent placed above and across the sphincter of Oddi in malignant bile duct obstruction. Gastrointest Endosc, 1998, 48:574～ 579.
